AVIEW CAC
Overview
AVIEW CAC by Coreline Soft Co. is an artificial intelligence-based software designed for the automated detection, segmentation, and quantification of coronary artery calcification (CAC). The tool utilizes deep learning algorithms to analyze cardiac structures and isolate calcified plaques within the coronary arteries. It generates quantitative metrics, including Agatston, volume, and mass scores, as well as vessel-specific breakdowns and age- and sex-adjusted percentiles.
The software is designed for radiologists, cardiologists, and imaging technologists operating in hospitals, imaging centers, and cardiovascular clinics. It is applicable to both dedicated electrocardiogram (ECG)-gated cardiac CT scans and routine, non-gated low-dose chest CT (LDCT) examinations, allowing clinicians to assess cardiovascular risk from scans performed for other diagnostic purposes.
AVIEW CAC integrates into standard clinical workflows by receiving DICOM data directly from CT scanners or Picture Archiving and Communication Systems (PACS). It processes images automatically or on-demand, returning structured scorecards and secondary capture reports directly to the PACS or radiological information systems (RIS) within minutes. Notable capabilities include:
- Atlas-guided deep learning to segment cardiac anatomy and minimize the misclassification of non-coronary calcium.
- Multi-modality compatibility supporting both ECG-gated and non-gated chest CT scans.
- Automated reporting that provides standardized, color-coded risk classifications and vessel-by-vessel Agatston scoring.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated coronary artery calcium (CAC) scoring
- Segmentation of four main coronary arteries (LM, LAD, LCX, RCA)
- Quantitative analysis of calcified plaques
- Agatston, volume, and mass score per branch
- Risk and age analysis by vessel
- Analysis from cardiac CT and chest CT images (including low-dose CT)
- Proprietary kernel conversion technology for improved accuracy
- Automatic report generation (PDF, CSV)
- Integration with PACS and RIS systems
- Web browser access
Use Cases
- Early detection of coronary artery disease
- Cardiovascular risk assessment and stratification
- Streamlining radiology workflows and reducing interpretation time
- Supporting patient communication and understanding of diagnosis
- Research purposes (data export to CSV)
- Population-based cardiovascular screening
What Physicians Need to Know
Leverage AVIEW CAC for efficient and accurate automated coronary artery calcium scoring from both dedicated cardiac CT and non-gated chest CT scans. Utilize the quantitative Agatston, volume, and mass scores, along with age and gender-based risk stratification, to enhance patient communication and guide preventive treatment strategies. The automated workflow can significantly reduce interpretation time and streamline reporting, allowing for faster clinical decision-making, particularly in high-volume settings. Consider its potential for opportunistic screening of cardiovascular disease when chest CTs are performed for other indications.
AVIEW CAC is designed for seamless integration into existing radiology workflows. It supports DICOM (TCP/IP) for data exchange with PACS and medical imaging equipment, and HL7 for integration with RIS. The platform is accessible via web browsers and mobile devices, facilitating convenient review of analyzed results and reports within the PACS system or remotely. Coreline Soft also partners with various AI platforms for broader deployment.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker), Server-based, Stand-alone third-party application, Stand-alone web-based, PC installation |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated AVIEW CAC received FDA 510(k) clearance in April 2024, with an enhanced version receiving clearance in February 2025. It is cleared as a Class II device for quantitative analysis of calcified plaques in coronary arteries using non-contrast/non-gated Chest CT scans, enabling calculation of Agatston score and risk stratification. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Radiology |
What the Web Says
AVIEW CAC by Coreline Soft is an AI-powered solution for analyzing coronary artery calcification (CAC) from CT scans. It has received FDA 510(k) clearance and is designed to assist healthcare professionals, including radiologists and cardiologists, in quantitatively analyzing calcified plaques and providing risk stratification. The software aims to reduce workload and improve diagnostic accuracy and efficiency in identifying cardiovascular disease risk.
Overall: PositiveStrengths
- High accuracy in detecting and quantifying coronary artery calcification, with reported 99.2% accuracy for risk categorization compared to expert interpretation.
- Reduces radiologist workload and interpretation time, with one study estimating a 71.2% reduction in workload.
- Provides quantitative CAC values comparable to those measured by professionals, without the need for heartbeat adjustment.
- Offers automated reports with detailed calcification scores, risk analysis by vessel, and age-based percentiles, which can be easily shared with patients.
- Can analyze existing non-contrast/non-gated chest CT studies, making it versatile for various clinical settings.
- Integrates with PACS systems, allowing for easy storage, transfer, and access to CT data.
Limitations
- Some studies suggest the need for optimization, particularly for detecting minimal calcium volumes.
- Currently, the device's use is limited to CT scans acquired on General Electric (GE) or its subsidiaries' equipment, and has not been validated for other manufacturers.
- While generally positive, some Reddit discussions about CAC scans in general indicate potential for anxiety with high scores or a false sense of security with low scores.
- No specific cons about AVIEW CAC were found on G2 or Capterra, as there were no direct reviews for this specific product on these platforms.
- Reddit discussions about CAC scans in general highlight that insurance often does not cover the cost, which could be a barrier for some patients.
- Some general discussions on Reddit indicate that a CAC score only measures hard plaque, and not soft plaque, which is more likely to rupture and cause a heart attack.
Based on reviews from: Coreline Soft, KBR (Korea Biomedical Review), accessdata.fda.gov, Hckonnect, AuntMinnie, PMC (PubMed Central), Reddit (r/GenX, r/PeterAttia, r/askCardiology)
Last updated: 2026-07-17
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate AVIEW CAC
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for AVIEW CAC.
[ENG] AVIEW CAC Introduction
Coreline
![[KOR] AVIEW CAC Introduction](https://i.ytimg.com/vi/lOusSdVwEB4/mqdefault.jpg)
![[GER] AVIEW LCS Plus Introduction](https://i.ytimg.com/vi/zeqRzMCHEl4/mqdefault.jpg)
![[ENG] AVIEW RT ACS Introduction](https://i.ytimg.com/vi/5wXe-xHmYhU/mqdefault.jpg)
![[ENG] AVIEW Research Introduction](https://i.ytimg.com/vi/AT02AieH3h4/mqdefault.jpg)
![[K-BIZ] u2018Coreline Soft(ucf54uc5b4ub77cuc778uc18cud504ud2b8)u2019, providing AI software for medical images](https://i.ytimg.com/vi/OjVuiYf1d6E/mqdefault.jpg)
